A Study to Assess the Safety, Tolerability, Pharmacokinetics & Efficacy of

See also
Status	Clinical Trial	Phase
Completed	`NCT01553994` - Effectiveness Study of Gardasil on Condyloma	N/A
Terminated	`NCT02115919` - Safety Study of Multikine in the Treatment of Perianal Warts	Phase 1
Recruiting	`NCT05087849` - Intralesional HPV Vaccine for Condylomata	Phase 1/Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT01553994 - Effectiveness Study of Gardasil on Condyloma

N/A

Terminated

NCT02115919 - Safety Study of Multikine in the Treatment of Perianal Warts

Phase 1

Recruiting

NCT05087849 - Intralesional HPV Vaccine for Condylomata

Phase 1/Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02724254
Study type	Interventional
Source	Vaxart
Contact
Status	Completed
Phase	Phase 2
Start date	January 2016
Completion date	July 2018

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms